New Vertex Cell Therapy for Diabetes to Hit the Clinic Soon

March 9, 2023

Shortly after receiving the nod from the US Food and Drug Administration (FDA), Vertex Pharma announced that it will soon bring its new application of its diabetes cell therapy to clinics by summer of this year. The therapy uses a special delivery method that removes the need for immune suppressants after delivering stem cells that can restore the function of insulin-producing pancreatic cells.

According to Annalee Armstrong, “Vertex made a splash in October 2021 with the announcement that a single patient had seen restored islet cell function after treatment with VX-880. The company said the results showed proof of concept for the approach, which uses insulin-producing pancreatic islet cells from donor stem cells. Restoration of these cells could allow patients to regulate insulin or even produce it on their own, rather than use daily insulin treatment or seek an islet cell transplant. Vertex has positioned the two therapies as potentially “curative” for the common and stubborn condition.”

To read more, click here.